
What Pharma Is Buying From AI Drug Discovery: Inside AstraZeneca’s insitro Deal
Dr. Dereck Mush, MD, MBAVenture fund
8VC lists infrastructure, IT, biology, health care, government and defense, and logistics as the cornerstones of its thesis. Besides investing, it builds companies itself through a build program and says it has started 42 companies since 2016. It also runs fellowships for engineers and for people working at the intersection of biology and IT. HTS covered 8VC as an investor in Coherence Neuro's $45 million round for neural recording technology in brain cancer.
8VC is an Austin venture firm that invests in and builds companies across infrastructure, biology, health care, defense, and logistics.

Dr. Dereck Mush, MD, MBA
Dr. Dereck Mush, MD, MBAThe HealthTech Signal
Chai Discovery triples its valuation as pharma buys into AI-designed molecules
Dr. Dereck Mush, MD, MBA
Dr. Dereck Mush, MD, MBAKeep exploring
Your daily HealthTech Signal
Get the latest HealthTech news, understand why it matters, and see where the industry is headed.



Read by teams at companies like: